G1 Therapeutics Inc COSELA Kickoff Analyst and Investor Summit - Corporate Call Transcript
Good morning, everyone, I hope you and yours are healthy and well. My name is Will Roberts. I'm the Vice President and Head of Corporate Communications and Investor Relations here at G1 Therapeutics. I'm excited to welcome you today to the G1 COSELA Kickoff, our 2021 investor event. It's a pack 2-hour agenda, which I'll get to in a moment, but first, a couple of things to keep in mind.
First of all, this presentation does include forward-looking statements. And actual results could differ materially from those expressed in or implied by these forward-looking statements. So for more information on these forward-looking statements, I recommend that you go to sec.gov or to our G1 Therapeutics website and take a look at our filings with the SEC.
Secondly, as you know, we'll be talking today about our product COSELA, the only proactive multilineage myeloprotection therapy, which was approved by the U.S. Food and Drug Administration on February 12 of this year to decrease the incidence of chemotherapy-induced
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
